Mar 31, 2022
The spring 2022 newsletter for Lung-MAP participating sites is now available.
Mar 4, 2022
Feb 15, 2022
Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO
Feb 14, 2022
Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy
Jan 7, 2022
Jan 4, 2022
Major financial hardship common after cancer diagnosis, despite insurance
Dec 24, 2021
Thank you for another extraordinary year, replete with extraordinary work!